Venous Thromboembolism following Two Doses of COVID-19 mRNA Vaccines in the US Population, 2020–2022
The COVID-19 mRNA vaccine is one of the most effective strategies used to fight against COVID-19. Recently, venous thromboembolism (VTE) events after COVID-19 mRNA vaccination have been reported in various research. Such a concern may hamper the ongoing COVID-19 vaccination campaign. Based on the US...
Main Authors: | Daoyuan Lai, Yan Dora Zhang, Junfeng Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/8/1317 |
Similar Items
-
Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System
by: Jung Yoon Choi, et al.
Published: (2024-03-01) -
Concomitant pulmonary tuberculosis and venous thromboembolism
by: K Gowrinath, et al.
Published: (2023-01-01) -
Preventing venous thromboembolism without causing harm
by: Aaron B Holley
Published: (2021-01-01) -
Prevention and treatment of venous thromboembolism
by: Casadei, B, et al.
Published: (2020) -
Venous Thromboembolism Following Travel
by: Morteza Izadi, et al.
Published: (2014-03-01)